(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
1.14% $ 5.32
@ $6.92
Emitido: 14 feb 2024 @ 14:05
Retorno: -23.07%
Señal anterior: feb 14 - 09:30
Señal anterior:
Retorno: -1.07 %
Live Chart Being Loaded With Signals
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally...
Stats | |
---|---|
Volumen de hoy | 512 701 |
Volumen promedio | 920 458 |
Capitalización de mercado | 392.60M |
EPS | $0 ( 2024-02-27 ) |
Próxima fecha de ganancias | ( $0.0400 ) 2024-05-08 |
Last Dividend | $1.600 ( 1998-01-08 ) |
Next Dividend | $0 ( N/A ) |
P/E | 7.39 |
ATR14 | $0.00300 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-26 | Datin James A | Buy | 3 217 | Common Stock |
2024-03-26 | Datin James A | Sell | 871 | Common Stock |
2024-03-01 | Mcgrath Kenneth J | Buy | 58 759 | Common Stock |
2024-03-01 | Mcgrath Kenneth J | Sell | 5 616 | Common Stock |
2024-03-01 | Anthony Michele Marie | Buy | 24 336 | Common Stock |
INSIDER POWER |
---|
67.98 |
Last 97 transactions |
Buy: 2 719 008 | Sell: 297 058 |
Volumen Correlación
OraSure Technologies Inc Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OraSure Technologies Inc Correlación - Moneda/Commodity
OraSure Technologies Inc Finanzas
Annual | 2023 |
Ingresos: | $405.47M |
Beneficio Bruto: | $179.42M (44.25 %) |
EPS: | $0.730 |
FY | 2023 |
Ingresos: | $405.47M |
Beneficio Bruto: | $179.42M (44.25 %) |
EPS: | $0.730 |
FY | 2022 |
Ingresos: | $387.48M |
Beneficio Bruto: | $147.64M (38.10 %) |
EPS: | $-0.250 |
FY | 2021 |
Ingresos: | $233.67M |
Beneficio Bruto: | $117.60M (50.33 %) |
EPS: | $-0.320 |
Financial Reports:
No articles found.
OraSure Technologies Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $1.600 | 1998-01-08 |
Last Dividend | $1.600 | 1998-01-08 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $1.600 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.32 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.02 | |
Div. Directional Score | 7.70 | -- |
Year | Amount | Yield |
---|---|---|
1998 | $1.600 | 29.80% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.132 | 1.500 | 7.35 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.111 | 1.200 | 6.30 | 7.56 | [0 - 0.3] |
returnOnEquityTTM | 0.132 | 1.500 | 9.64 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 9.77 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 8.36 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 7.35 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0280 | -1.500 | 9.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.575 | 2.00 | 9.47 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.435 | 2.00 | 9.28 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0314 | -1.500 | 9.87 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.425 | 1.000 | 6.26 | 6.26 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0901 | 1.000 | -0.198 | -0.198 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 8.57 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.840 | 0.800 | 7.73 | 6.19 | [0.5 - 2] |
Total Score | 11.37 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 7.29 | 1.000 | 9.36 | 0 | [1 - 100] |
returnOnEquityTTM | 0.132 | 2.50 | 9.77 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.435 | 2.00 | 9.52 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.575 | 2.00 | 9.47 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0486 | 1.500 | -3.01 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.286 | 1.000 | 5.36 | 0 | [0.1 - 0.5] |
Total Score | 4.02 |
OraSure Technologies Inc
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico